The Recall Desk

Hazard

Wrong Medication recalls

90 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
90
Critical
9
Severe
58
Most recent
2026-07-01

Of the 90 wrong medication recalls we have scored against our rubric, 9 (10%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 58 (64%) are Severe.

Which agencies issued them

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all wrong medication recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

26–50 of 90

  • CriticalFDA (Drugs)·D-1589-2014·2014-09-24

    American Health Packaging Recalls Mis-Labeled Ibuprofen Tablets

    American Health Packaging is recalling 137,300 Ibuprofen 600 mg tablets because some cartons were mis-labeled as Oxcarbazepine 300 mg.

    Product
    Ibuprofen Tablets, USP, 600 mg, 100 tablets per carton (10 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, OH 43217, NDC 68084-0703-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1590-2014·2014-09-24

    Oxcarbazepine Tablets Recalled Due to Labeling Error

    American Health Packaging is recalling Oxcarbazepine Tablets due to a label mix-up with Ibuprofen tablets.

    Product
    Oxcarbazepine Tablets, 300 mg, 100 tablets per carton (10 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, OH 43217, NDC 62584-143-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1446-2014·2014-07-30

    Shamrock Medical Recalls Mislabelled Diltiazem Capsules Packaged as Thiamine

    Shamrock Medical Solutions is recalling Diltiazem HCl capsules that were incorrectly labeled as Thiamine. The error could lead to patients receiving the wrong medication.

    Product
    Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: Shamrock Medical Solutions, Lewis Center, Ohio, Mfg: Watson Laboratories, Corona, CA NDC 62037-0696-90
    Category
    Drug
    Distribution
    5 states
  • SevereFDA (Drugs)·D-1449-2014·2014-07-30

    Shamrock Medical Recalls Mislabelled Pramipexole Tablets Packaged as Nebivolol

    Shamrock Medical Solutions is recalling Pramipexole Dihydrochloride tablets that were incorrectly labeled as Nebivolol. The error poses a risk of patients receiving the wrong medication.

    Product
    Pramipexole Dihydrochloride Tablets, 0.5 mg, Rx, packaged and labeled to contain Nebivolol tablets, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Northstar Rx, Memphis, TN NDC 16714-586-01
    Category
    Drug
    Distribution
    5 states
  • HighFDA (Drugs)·D-1363-2014·2014-06-18

    Pantoprazole Sodium Tablets Recalled Due to Potential Mispackaging with Lorazepam

    Legacy Pharmaceutical Packaging is recalling Pantoprazole Sodium tablets because some cartons may contain Lorazepam tablets instead.

    Product
    Pantoprazole Sodium, Delayed-release tablets, USP, 40 mg tablets, 100 (10x10) unit dose packages, Manufactured by Dr. Reddy's Laboratories Limited, India and Distributed by Major Pharmaceuticals, Livonia, MI --- NDC 0904-6235-61
    Category
    Drug
    Distribution
    1 state
  • CriticalFDA (Drugs)·D-1328-2014·2014-05-28

    Pfizer Recalls Effexor XR Capsules Due to Foreign Tablet Contamination

    Pfizer is recalling specific lots of Effexor XR 150 mg capsules because a foreign Tikosyn capsule was found in a bottle.

    Product
    Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg, packaged in a) 30-count Unit of Use bottles (NDC 0008-0836-21) UPC 3 0008-0836-21 7; b) 90-count Unit of Use bottles (NDC 0008-0836-22) UPC 3 0008-0836-22 4; Rx only, Distributed by Wyeth Pharmaceuticals Inc., A subs
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1229-2014·2014-04-16

    Glenmark Recalls Ranitidine Tablets Due to Foreign Metoprolol Contamination

    Glenmark Generics Inc. is recalling specific bottles of Ranitidine Tablets USP 150 mg because they were found to contain foreign Metoprolol Tartrate tablets.

    Product
    Ranitidine Tablets USP, 150 mg, 500-count bottles, Rx only, Manufactured by: Shasun Pharmaceuticals Limited, Unit-II R.S. No 32 33 & 34, Shasun Road, Periyakalapet, Puducherry, - 605 014, India; Manufactured for: Glenmark Generics Inc, USA, Mahwah, NJ 07430, UPC 3 68462 24805 8,
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-978-2014·2014-01-29

    Aidapak Recalls Minocycline Capsules Due to Potential Labeling Error

    Aidapak Services, LLC is recalling Minocycline HCL capsules because they may have been mislabeled as Minoxidil tablets. The error could lead to patients receiving the wrong medication.

    Product
    MINOCYCLINE HCL, Capsule, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591569401.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-1026-2014·2014-01-29

    Aidapak Recalls Tri-Buffered Aspirin Tablets Due to Labeling Error

    Aidapak Services is recalling Tri-Buffered Aspirin tablets because they may have been mislabeled as a different medication. The error involves a potential mix-up with Isometheptene Mucate/Dichlorphenazone/APAP capsules.

    Product
    TRI-BUFFERED ASPIRIN, Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904201559.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-854-2014·2014-01-29

    Aidapak Recalls Mislabeled glyBURIDE Tablets Due to Labeling Error

    Aidapak Services, LLC is recalling glyBURIDE tablets that may have been mislabeled as other prescription drugs. The error poses a risk of patients receiving incorrect medication.

    Product
    glyBURIDE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093834301.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-815-2014·2014-01-29

    FDA Recalls Valsartan Tablets Due to Potential Labeling Mixup

    Aidapak Services, LLC is recalling Valsartan 80 mg tablets because they may have been mislabeled as other prescription drugs.

    Product
    VALSARTAN, Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078035834.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-855-2014·2014-01-29

    FDA Recalls MEXILETINE HCL Capsules Due to Potential Labeling Error

    Aidapak Services, LLC is recalling MEXILETINE HCL capsules because they may have been mislabeled as CALCIUM ACETATE. The error could lead to patients receiving the wrong medication.

    Product
    MEXILETINE HCL, Capsule, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093873901.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-998-2014·2014-01-29

    FDA Recalls Perphenazine Tablets Due to Potential Label Mixup

    Aidapak Services is recalling 16 mg Perphenazine tablets because they may have been mislabeled as other prescription drugs.

    Product
    PERPHENAZINE, Tablet, 16 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781104901.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-1006-2014·2014-01-29

    Tacrolimus Capsules Recalled for Potential Labeling Mixup

    Aidapak Services is recalling 0.5 mg tacrolimus capsules because they may have been mislabeled as cinacalcet or isosorbide mononitrate.

    Product
    TACROLIMUS, Capsule, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781210201.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-850-2014·2014-01-29

    Aidapak Recalls Glyburide Tablets Due to Potential Label Mixup

    Aidapak Services is recalling glyBURIDE MICRONIZED tablets because they may have been mislabeled as digoxin. The error could lead to patients receiving the wrong medication.

    Product
    glyBURIDE MICRONIZED, Tablet, 3 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093803501.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-795-2014·2014-01-29

    Aidapak Recalls Acarbose Tablets Due to Potential Labeling Errors

    Aidapak Services, LLC is recalling Acarbose 25 mg tablets because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.

    Product
    ACARBOSE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054014025.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-900-2014·2014-01-29

    Aidapak Recalls Atorvastatin Calcium Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling Atorvastatin Calcium 10 mg tablets because they may have been mislabeled as other prescription drugs.

    Product
    ATORVASTATIN CALCIUM, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378201577.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-979-2014·2014-01-29

    Aidapak Recalls Minocycline Capsules Due to Potential Label Mixup

    Aidapak Services, LLC is recalling Minocycline HCL capsules that may have been mislabeled as Progesterone. The repacked drugs were distributed in four western states.

    Product
    MINOCYCLINE HCL, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591569550.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-786-2014·2014-01-29

    FDA Recalls Repacked Progesterone Capsules Due to Potential Labeling Error

    Aidapak Services is recalling repacked progesterone capsules that may be mislabeled as levothyroxine sodium tablets. The error could lead to patients receiving the wrong medication.

    Product
    PROGESTERONE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00032170801.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-961-2014·2014-01-29

    Aidapak Recalls Loxapine Capsules Due to Potential Sertraline Labeling Error

    Aidapak Services, LLC is recalling Loxapine 5 mg capsules that may have been mislabeled as Sertraline HCL 50 mg tablets. The repacked drugs were distributed in four western states.

    Product
    LOXAPINE, Capsule, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591036901.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-982-2014·2014-01-29

    FDA Recalls Mislabeled Acetaminophen, Butalbital, and Caffeine Tablets

    Aidapak Services, LLC is recalling Acetaminophen/Butalbital/Caffeine tablets that may have been mislabeled as Aspirin. The error could cause patients to take the wrong medication.

    Product
    ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603254421.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-861-2014·2014-01-29

    Aidapak Recalls Digoxin Tablets Due to Potential Label Mixup

    Aidapak Services is recalling Digoxin tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.

    Product
    DIGOXIN, Tablet, 0.125 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00115981101.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-873-2014·2014-01-29

    Dutasteride Capsules Recalled for Potential Labeling Mixup

    Aidapak Services is recalling 0.5 mg dutasteride capsules because they may have been mislabeled as phenol, repaglinide, or cholecalciferol.

    Product
    DUTASTERIDE, Capsule, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00173071215.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-879-2014·2014-01-29

    Aidapak Recalls Lovastatin Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling 20 mg Lovastatin tablets because they may have been mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.

    Product
    LOVASTATIN, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185007201.
    Category
    Drug
    Distribution
    4 states